Acumen Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 08/14/2025 | 14.93 M | $17.32 M | 0.00% | 24.65% |
SANDS CAPITAL VENTURES, LLC | 08/13/2025 | 3.42 M | $3.96 M | 0.00% | 5.64% |
FRANKLIN RESOURCES INC | 08/12/2025 | 3.08 M | $3.57 M | -2.07% | 5.08% |
FMR LLC | 08/14/2025 | 2.03 M | $2.35 M | 0.20% | 3.35% |
MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 1.95 M | $2.26 M | 71.78% | 3.22% |
VANGUARD GROUP INC | 08/11/2025 | 1.69 M | $1.96 M | -12.78% | 2.79% |
KNOLLWOOD INVESTMENT ADVISORY, LLC | 08/13/2025 | 1.63 M | $1.89 M | 0.00% | 2.69% |
PATHSTONE HOLDINGS, LLC | 08/12/2025 | 1.06 M | $1.23 M | -2.58% | 1.75% |
ALYESKA INVESTMENT GROUP, L.P. | 08/14/2025 | 939.60 K | $1.09 M | 0.00% | 1.55% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 916.18 K | $1.06 M | 526.74% | 1.51% |
LAURION CAPITAL MANAGEMENT LP | 08/14/2025 | 867.05 K | $1.01 M | 0.00% | 1.43% |
HUDSON BAY CAPITAL MANAGEMENT LP | 08/18/2025 | 825.00 K | $957.01 K | 7.14% | 1.36% |
TWO SIGMA ADVISERS, LP | 08/14/2025 | 426.30 K | $494.51 K | -8.07% | 0.70% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 396.63 K | $460.17 K | -53.98% | 0.65% |
GOLDMAN SACHS GROUP INC | 08/14/2025 | 334.68 K | $388.23 K | 70.58% | 0.55% |
BLACKROCK, INC. | 08/12/2025 | 291.96 K | $338.67 K | -87.48% | 0.48% |
IKARIAN CAPITAL, LLC | 08/14/2025 | 265.77 K | $308.29 K | 0.00% | 0.44% |
Y-INTERCEPT (HONG KONG) LTD | 08/01/2025 | 250.85 K | $290.98 K | 100.00% | 0.41% |
RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 246.59 K | $286.04 K | -3.94% | 0.41% |
TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 200.79 K | $232.91 K | -13.56% | 0.33% |
JANE STREET GROUP, LLC | 08/14/2025 | 175.67 K | $203.78 K | 1,525.97% | 0.29% |
MORGAN STANLEY | 08/15/2025 | 153.75 K | $178.35 K | 0.73% | 0.25% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 152.34 K | $176.71 K | 37.27% | 0.25% |
BANK OF AMERICA CORP /DE/ | 08/14/2025 | 147.01 K | $170.53 K | -7.50% | 0.24% |
MARSHALL WACE, LLP | 08/13/2025 | 137.94 K | $160.01 K | 100.00% | 0.23% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2025 | 115.17 K | $133.60 K | 0.00% | 0.19% |
STATE STREET CORP | 08/14/2025 | 106.68 K | $123.75 K | -79.53% | 0.18% |
UBS GROUP AG | 08/14/2025 | 94.42 K | $109.53 K | -23.24% | 0.16% |
CATALYST FINANCIAL PARTNERS LLC | 08/14/2025 | 89.70 K | $104.05 K | 0.00% | 0.15% |
NORTHERN TRUST CORP | 08/13/2025 | 65.16 K | $75.59 K | -77.52% | 0.11% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2025 | 57.56 K | $66.77 K | 160.04% | 0.10% |
BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2025 | 51.04 K | $59.21 K | 0.00% | 0.08% |
AQR CAPITAL MANAGEMENT LLC | 08/14/2025 | 46.29 K | $53.70 K | 10.92% | 0.08% |
DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 43.52 K | $50.49 K | 0.00% | 0.07% |
JAIN GLOBAL LLC | 08/14/2025 | 39.99 K | $46.39 K | 100.00% | 0.07% |
MAREX GROUP PLC | 08/19/2025 | 33.30 K | $38.63 K | 100.00% | 0.06% |
GSA CAPITAL PARTNERS LLP | 07/22/2025 | 32.10 K | $37.00 K | 100.00% | 0.05% |
HRT FINANCIAL LP | 08/14/2025 | 31.43 K | $36.00 K | 100.00% | 0.05% |
INTREPID FINANCIAL PLANNING GROUP LLC | 08/11/2025 | 30.15 K | $34.97 K | 0.00% | 0.05% |
BARCLAYS PLC | 08/14/2025 | 29.99 K | $35.00 K | -58.50% | 0.05% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 08/14/2025 | 21.34 K | $24.75 K | 100.00% | 0.04% |
TWO SIGMA SECURITIES, LLC | 08/14/2025 | 20.07 K | $23.28 K | 68.92% | 0.03% |
CATALYST FUNDS MANAGEMENT PTY LTD | 08/12/2025 | 19.70 K | $22.85 K | 100.00% | 0.03% |
PINNACLE ASSOCIATES LTD | 08/04/2025 | 18.02 K | $20.90 K | 0.00% | 0.03% |
PINNACLE WEALTH MANAGEMENT ADVISORY GROUP, LLC | 08/07/2025 | 18.02 K | $20.90 K | 0.00% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 17.20 K | $19.95 K | 100.00% | 0.03% |
JPMORGAN CHASE & CO | 08/12/2025 | 16.68 K | $29.18 K | -98.00% | 0.03% |
CLUNE & ASSOCIATES, LTD. | 07/30/2025 | 16.50 K | $19.14 K | 0.00% | 0.03% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2025 | 15.93 K | $18.48 K | 100.00% | 0.03% |
CITADEL ADVISORS LLC | 08/14/2025 | 14.30 K | $16.59 K | -63.43% | 0.02% |
Acumen Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 105 institutional investors and hedge funds held shares of Acumen Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 14.93 M
Sands Capital Ventures, LLC: 3.42 M
FRANKLIN RESOURCES INC: 3.08 M
FMR LLC: 2.03 M
MILLENNIUM MANAGEMENT LLC: 1.95 M
VANGUARD GROUP INC: 1.69 M
62.08% of Acumen Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 40.49 M shares in the last 24 months. This purchase volume represents approximately $78.96 M in transactions.